Laparoscopic sleeve gastrectomy and medical management for the treatment of type 2 diabetes mellitus in non-morbidly obese patients: A single-center experience

Diabetes Technology and Therapeutics

Volumn 15, Issue 4, 2013, Pages 281-288

  Desiderio, Jacopo ^a   Trastulli, Stefano ^a   Scalercio, Vittorio ^a   Cirocchi, Roberto ^b   Carloni, Giancarlo ^a   Moriconi, Eleonora ^b   Boselli, Carlo ^b   Noya, Giuseppe ^b   Parisi, Amilcare ^a  

^a St Maria Hospital   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETIC OBESITY; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; SLEEVE GASTRECTOMY; TREATMENT OUTCOME; WEIGHT REDUCTION;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY; PRACTICE GUIDELINES AS TOPIC; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84876118751     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0308     Document Type: Article

References (28)

1. Naser KA, Gruber A, Thomson GA: The emerging pandemic of obesity and diabetes: Are we doing enough to prevent a disaster? Int J Clin Pract 2006;60:1093-1097.
2. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i- xii, 1-253.
3. Standards of medical care in diabetes - 2009. Diabetes Care 2009;32(Suppl 1):S13- S61.
4. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. WMJ 1998;97:20-21, 24-25, 27-37.
5. Nandagopal R, Brown RJ, Rother KI: Resolution of type 2 diabetes following bariatric surgery: Implications for adults and adolescents. Diabetes Technol Ther 2010;12:671-677.
6. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292:1724-1737.
7. Ren CJ, Patterson E, Gagner M: Early results of laparoscopic biliopancreatic diversion with duodenal switch: A case series of 40 consecutive patients. Obes Surg 2000;10:514-523; discussion 524.
8. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N: Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010;24:1005-1010.
9. Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, Basso N: Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 2010;20:50-55.
10. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32:193-203.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
12. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL, Robertson RP, Rubino F, Kahn R, Kirkman MS: How do we define cure of diabetes? Diabetes Care 2009;32:2133-2135.
13. Streiner DL, Norman GR: Health Measurement Scales. A Practical Guide to Their Development and Use, 2nd ed. New York: Oxford University Press, 1989.
14. Ware J Jr, Kosinski M, Keller SD: A 12-item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
15. Shamseddeen H, Getty JZ, Hamdallah IN, Ali MR: Epidemiology and economic impact of obesity and type 2 diabetes. Surg Clin North Am 2011;91:1163-1172, vii.
16. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblan D, Flores L, Lacy A: Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008;18:1077-1082.
17. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL: Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-1576.
18. Cutolo PP, Nosso G, Vitolo G, Brancato V, Capaldo B, Angrisani L: Clinical efficacy of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass in obese type 2 diabetic patients: A retrospective comparison. Obes Surg 2012;22: 1535-1539.
19. Rao RS, Yanagisawa R, Kini S: Insulin resistance and bariatric surgery. Obes Rev 2012;13:316-328.
20. Ferrannini E, Mingrone G: Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 2009;32:514-520.
21. Bayham BE, Greenway FL, Bellanger DE, O'Neil CE: Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy. Diabetes Technol Ther 2012;14:30-34.
22. Gumbs AA, Modlin IM, Ballantyne GH: Changes in insulin resistance following bariatric surgery: Role of caloric restriction and weight loss. Obes Surg 2005;15:462-473.
23. Rubino F, Gagner M: Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002;236:554-559.
24. Leonetti F, Silecchia G, Iacobellis G, Ribaudo MC, Zappaterreno A, Tiberti C, Iannucci CV, Perrotta N, Bacci V, Basso MS, Basso N, Di Mario U: Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab 2003;88:4227-4231.
25. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK: Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: A prospective, double blind study. Ann Surg 2008;247:401-407.
26. Peterli R, Wolnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Flue M, Beglinger C: Improvement in glucose metabolism after bariatric surgery: Comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: A prospective randomized trial. Ann Surg 2009;250:234-241.
27. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I: Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med 2009;122:248-256.e245.
28. Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, Maglio C, Coccia F, Borgonuovo G, De Luca ML, Asprino R, Alessandri G, Casella G, Leonetti F: First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: The gastric hypothesis. Surg Endosc 2011;25:3540-3550.